Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00281203 · ClinicalTrials.gov registry record

Comparison of Alveolar Macrophages in Healthy Individuals Versus Individuals With COPD

A clinical trial, sponsored by University of Michigan.

Completed
Registry status
32
Enrollment target

NCT00281203: Completed study, sponsored by University of Michigan.

NCT00281203 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00281203 has completed, sponsored by University of Michigan.

COMPLETED
Registry status
32 participants
Enrollment target

Study Summary

This study group forms the normal subject control group in an experiment designed to determine whether the alveolar macrophages (AMø) of patients with chronic obstructive pulmonary disease (COPD) show abnormal responsiveness to bacterial and viral products. Specifically, the study will determine the dose-response characteristics of AMø for production of interleukin (IL)-6, IL-18, and IL-23 (pro-inflammatory cytokines) on stimulation by purified lipopolysaccharide, a synthetic lipopeptide (PAM3-Cys), or poly I:C. These stimuli mimic the response to Gram-negative bacteria, Gram-positive bacteria, and RNA viruses, respectively. Results of the AMø from these healthy volunteers will be compared with AMø of COPD patients and smokers (or ex-smokers) with normal pulmonary function; those samples are being obtained during clinically indicated bronchoscopies under a separate consent form.

Interventions

  • PROCEDURE blood drawing
  • PROCEDURE fiberoptic bronchoscopy

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2005-09
Est. Completion 2010-07
University of Michigan

1,327 total trials

What the finished NCT00281203 record still lists

NCT00281203 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.

The record links to 0 conditions, and to 2 interventions - of which blood drawing is the first listed.

NCT00281203 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00281203 about?

NCT00281203 is a clinical study titled "Comparison of Alveolar Macrophages in Healthy Individuals Versus Individuals With COPD". This study group forms the normal subject control group in an experiment designed to determine whether the alveolar macrophages (AMø) of patients with chronic obstructive pulmonary disease (COPD) show abnormal responsiveness to bacterial and viral products. Specifically, the study will determine the...

What is the current status of trial NCT00281203?

This trial is currently completed. The enrollment target is 32 participants. The study started on 2005-09. Estimated completion is 2010-07.

What interventions are being tested in trial NCT00281203?

The interventions under investigation include: blood drawing (PROCEDURE), fiberoptic bronchoscopy (PROCEDURE).

Who is sponsoring clinical trial NCT00281203?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00281203, the US trial registry maintained by the National Library of Medicine. NCT00281203 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.